Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Pollock

Showing results (241-250 of 327) with videos related to

Pageof 33
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Nortriptyline Side Effects During Double-Blind, Randomized, Placebo-Controlled Maintenance Therapy in Older Depressed PatientsCharles F Reynolds, Ellen Frank, James M Perel, et al.
Alzheimer'S Research & Therapy|August 7, 2023
Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer's dementiaHamed Azami, Christoph Zrenner, Heather Brooks, et al.
International Journal of Geriatric Psychiatry|July 16, 2005
Late-onset major depression: clinical and treatment-response variabilityHenry C Driscoll, James Basinski, Benoit H Mulsant, et al.
Synapse (New York, N.Y.)|July 12, 2002
Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjectsGwenn S Smith, Yilong Ma, Vijay Dhawan, et al.
International Psychogeriatrics|May 13, 2022
Impact of standardizing care for agitation in dementia using an integrated care pathway on an inpatient geriatric psychiatry unitSanjeev Kumar, Amruta Shanbhag, Amer M Burhan, et al.
The Journal of Clinical Psychiatry|January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With SchizophreniaYusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2021
Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older AdultsSusmita Chandramouleeshwaran, Naba Ahsan, Roger Raymond, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 21, 2023
Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive DisorderVivian Feng, Krista Lanctot, Nathan Herrmann, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Pageof 33

Showing results (241-250 of 327) with videos related to

Sort By:
Pageof 33
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Nortriptyline Side Effects During Double-Blind, Randomized, Placebo-Controlled Maintenance Therapy in Older Depressed PatientsCharles F Reynolds, Ellen Frank, James M Perel, et al.
Alzheimer'S Research & Therapy|August 7, 2023
Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer's dementiaHamed Azami, Christoph Zrenner, Heather Brooks, et al.
International Journal of Geriatric Psychiatry|July 16, 2005
Late-onset major depression: clinical and treatment-response variabilityHenry C Driscoll, James Basinski, Benoit H Mulsant, et al.
Synapse (New York, N.Y.)|July 12, 2002
Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjectsGwenn S Smith, Yilong Ma, Vijay Dhawan, et al.
International Psychogeriatrics|May 13, 2022
Impact of standardizing care for agitation in dementia using an integrated care pathway on an inpatient geriatric psychiatry unitSanjeev Kumar, Amruta Shanbhag, Amer M Burhan, et al.
The Journal of Clinical Psychiatry|January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With SchizophreniaYusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2021
Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older AdultsSusmita Chandramouleeshwaran, Naba Ahsan, Roger Raymond, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 21, 2023
Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive DisorderVivian Feng, Krista Lanctot, Nathan Herrmann, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Pageof 33